Research Article
Antibacterial and Antibiotic Modifying Potential of Crude Extracts, Fractions, and Compounds from Acacia polyacantha Willd. against MDR Gram-Negative Bacteria
Table 3
MICs (in μg/mL) of crude leaf extract (APL), active fractions (APLa and APLd), 3-O-[β-galactopyranosyl-(1→4)-β-galactopyranosyl]-oleanolic acid (8) and chloramphenicol in the presence of PAßN and fold increase of activity (in parenthesis) against a panel of selected Gram-negative bacteria.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(-): MIC > 1024 μg/mL for crude extract APL, >512 for fractions APLb and APLd, 256 μg/mL for 3-O-[β-galactopyranosyl-(1→4)-β-galactopyranosyl]-oleanolic acid (8); (): values in parenthesis are fold increase of activity in the presence of PAßN at 30 μg/mL; MIC values in bold: significant antibacterial effects for MIC [18] and significant increase of activity in the presence of PAßN [19, 20]; fold increase of activity determined MIC of sample tested alone (Tables 1 and 2) versus MIC of the sample in the presence of PAßN. The MIC of PAßN was >256 mg/L for E. coli, E. aerogenes, K. pneumoniae, P. aerogenes, and P. stuartii strains. |